Mumbai-based medical tourism discovery platform CureMeAbroad has raised $600K in a pre-seed funding round led by investors including Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, and Vikrant Potnis. The fresh capital will be utilized to enhance its AI-driven cost estimator, strengthen clinical matching models, and expand its multilingual patient intelligence layer that powers its discovery engine.

Founded in June 2025 by Aditya Oza and Mikhail Bohra, CureMeAbroad connects international patients with more than 6,000 hospitals and over 3,800 accredited partners across 47 countries and 45 medical specialties. Key medical tourism hubs on the platform include Mexico, Turkey, Thailand, India, and Georgia. Its HIPAA-aligned AI estimator is trained on over 634 procedure records, enabling transparent and reliable cost insights.

With the global medical tourism market projected to reach $174 billion by 2035, the company aims to expand into the GCC, UK, and Africa while addressing pricing opacity, fragmented aftercare, and unstructured patient journeys through a trusted AI-powered marketplace.